Ann: Regeneus and Kyocera sign Progenza OA deal, page-3

First 3 Last

Share
Profile

Follow
TDA

11,411 Posts.

137

11/08/20

10:04

Post #: 46444649
Share

Originally posted by Biotechasx ↑

WOW..... HUGE !!

Regeneus and Kyocera sign Progenza OA licence and collaborationagreement
Highlights:•Regeneusand Kyocera havesigned alicence and collaborationagreement for Kyocera to exclusively develop and commercialise Regeneus’ lead stem cell platform technology Progenza for the treatment of Knee Osteoarthritis (Knee OA) in Japan•Regeneus to receiveUS$19m(A$27m)in upfront, development and regulatory milestone payments•Additional single to high double-digit royalties on Progenza OA product sales in Japan based on future reimbursement prices•Kyocera will fund manufacturing, development, and commercialisation costs for Progenza OA in Japan under the agreement •Upfront payment provides cash runway for Regeneus through to thecommercial launch of ProgenzaOA in Japan•The global market for osteoarthritis is expected to grow to US$3.5 billion by 2026 with the Japanese market worthUS$350 million1. The potential osteoarthritis patient population is 25.6 million in Japan with 1.25 million people receiving treatment, and is expected to rise each year2.Regeneus Ltd (ASX: RGS)(Regeneusor the Company), a clinical-stage regenerative medicine company,today announced that KyoceraCorporation (Kyocera, TYO:6971) has signed a licence agreement to develop and commercialise Progenza for Knee Osteoarthritis (Progenza OA) in Japan. ProgenzaOAhas already completedaPhase I study which met all safety and efficacy endpoints. The study demonstrated that a single injectionof ProgenzaOAinto the knee was safe, tolerable and showed significant, rapid and sustained reductions in knee pain for osteoarthritis patients,andshowed positive signs of disease modification showing no deterioration in the joint following the injection. The licence and collaborationagreement follows the two companies signing a Memorandum of Understanding (MOU) in March 2020, and Kyocera completing detailed due diligence on ProgenzaOA.

Expand

We get another $11m into the coffers straight away too!

Well done to the team, much more to come now outside of Japan with other licensing deals for both platforms!!

RGS Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Finance school vs reality: What they don't teach you about the stock market

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

There are more pages in this discussion • 81 more messages in this thread...

First 3 Last

Add CMB (ASX) to my watchlist

(20min delay)
Last 46.0¢		Change 0.005(1.10%)		Mkt cap ! $5.488M

Open	High	Low	Value	Volume
46.0¢	46.0¢	46.0¢	$0	1

Buyers (Bids)

No.	Vol.	Price($)
1	1200	42.0¢

Sellers (Offers)

Price($)	Vol.	No.
45.5¢	8	1

View Market Depth

No.	Vol.	Price($)
1	1200	0.420
1	4314	0.410
1	400	0.400
1	6000	0.390
2	13292	0.380

Price($)	Vol.	No.
0.455	8	1
0.480	24	1
0.500	334	1
0.545	400	1
0.000	0	0

Last trade - 14.59pm 28/10/2024 (20 minute delay)

CMB (ASX) Chart

Ann: Regeneus and Kyocera sign Progenza OA deal, page-3

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Finance school vs reality: What they don't teach you about the stock market

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Regeneus and Kyocera sign Progenza OA deal, page-3

Top Stories

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Finance school vs reality: What they don't teach you about the stock market

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News